Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

000_cdcdc

COVID-19 less severe in paediatric patients, according to the CDC

April 8, 2020 Research and Development COVID-19, coronavirus

The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …
News
insulin

Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19

April 8, 2020 Research and Development Eli Lilly, diabetes, insulin

Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …
News
partnership

Second Genome to help drive development of Gilead therapies in potential $1.5bn deal

April 8, 2020 Research and Development Gilead, Second Genome, pharma

Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …
News
00000000_trumpyy

Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers

April 8, 2020 Research and Development COVID-19, coronavirus, covid 19, hydroxychloroquine

Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has …
News
stock-incyte-01-shutter

Incyte’s ruxolitinib cream formulations look strong in Phase 3 atopic dermatitis

April 7, 2020 Manufacturing and Production, Research and Development Incyte, atopic dermatitis, ruxolitinib

Incyte has lifted the curtain on promising new Phase 3 data for its 0.75% and 1.5% twice daily cream formulations …
News
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
Appointment
john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
Appointment
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
Appointment
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has …
News
merckwindow_web

MSD’s Keytruda hits Phase 3 main goal in first-line colorectal cancer sub-population

April 3, 2020 Medical Communications, Research and Development MSD, colorectal cancer, keytruda, pharma

MSD has lifted the veil on new Phase 3 for its blockbuster immunotherapy Keytruda, showing that the anti-PD-1 therapy met …
News

Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis

April 3, 2020 Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma

Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …
News
eusa

EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients

April 2, 2020 Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab

EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …
News
000000000000000_tttt

Researchers modify T-cells to identify and target multiple sites on leukaemia cells

April 1, 2020 Research and Development Cancer, Cancers, children cancer, leukaemia

Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …
News
pharmafocus_april_2020_cover

The April 2020 issue of Pharmafocus is available to read free online now!

April 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
News
00000000_fda

FDA aims to accelerate COVID-19 therapies with new programme

April 1, 2020 Research and Development COVID-19, FDA, america, coronaviurs

The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026